ATF2 - activating transcription factor 2 Gene
Species: Canis lupus familiaris (sub-species: familiaris)
Gene Type: protein coding
Gene ID: 478806
ATF2 Products (15)
| mRNA | Protein | Name |
|---|---|---|
| XM_038447132.1 | XP_038303060.1 | cyclic AMP-dependent transcription factor ATF-2 isoform X1 |
| XM_038447122.1 | XP_038303050.1 | cyclic AMP-dependent transcription factor ATF-2 isoform X1 |
| XM_038447125.1 | XP_038303053.1 | cyclic AMP-dependent transcription factor ATF-2 isoform X1 |
| XM_038447127.1 | XP_038303055.1 | cyclic AMP-dependent transcription factor ATF-2 isoform X1 |
| XM_038447126.1 | XP_038303054.1 | cyclic AMP-dependent transcription factor ATF-2 isoform X1 |
| XM_038447124.1 | XP_038303052.1 | cyclic AMP-dependent transcription factor ATF-2 isoform X1 |
| XM_038447123.1 | XP_038303051.1 | cyclic AMP-dependent transcription factor ATF-2 isoform X1 |
| XM_038447128.1 | XP_038303056.1 | cyclic AMP-dependent transcription factor ATF-2 isoform X1 |
| XM_038447131.1 | XP_038303059.1 | cyclic AMP-dependent transcription factor ATF-2 isoform X1 |
| XM_038447130.1 | XP_038303058.1 | cyclic AMP-dependent transcription factor ATF-2 isoform X1 |
| XM_038447129.1 | XP_038303057.1 | cyclic AMP-dependent transcription factor ATF-2 isoform X1 |
| XM_038447133.1 | XP_038303061.1 | cyclic AMP-dependent transcription factor ATF-2 isoform X2 |
| XM_038447135.1 | XP_038303063.1 | cyclic AMP-dependent transcription factor ATF-2 isoform X2 |
| XM_038447134.1 | XP_038303062.1 | cyclic AMP-dependent transcription factor ATF-2 isoform X2 |
| XM_038447136.1 | XP_038303064.1 | cyclic AMP-dependent transcription factor ATF-2 isoform X3 |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
cyclic AMP-dependent transcription factor ATF-2 |
|
Related Agents
- Approval
- Clinical Phase
- Pre-clinical Phase
Approval
Bioactive Molecules
(2)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-B1198 | Piperonyl butoxide | Inhibitor | 98.0% | Unkown |
| HY-B1198R | Piperonyl butoxide (Standard) | Inhibitor | / | Unkown |
Clinical Phase
Bioactive Molecules
(2)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase
|
|---|---|---|---|---|
| HY-13241 | Ralimetinib dimesylate | 99.97% | Phase 2 | |
| HY-13241A | Ralimetinib | Inhibitor | 98.58% | Phase 2 |
Pre-clinical Phase
Bioactive Molecules
(11)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-152860 | Darizmetinib | 99.94% | Unkown | |
| HY-134963 | SBI-0087702 | 99.55% | Unkown | |
| HY-117987 | CPS-11 | 99.39% | Unkown | |
| HY-B1198S | Piperonyl butoxide-d9 | Inhibitor | 98.68% | Unkown |
| HY-RS01128 | ATF2 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W585976 | Benzo[a]pyrene diol epoxide | / | Unkown | |
| HY-180419 | SF-3-030 | / | Unkown | |
| HY-RS05361 | GDNF Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-107091R | Aspartyl-alanyl-diketopiperazine (Standard) | Inhibitor | / | Unkown |
| HY-RS17003 | Atf2 Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS23446 | Atf2 Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service